The successful creation of human platelets by researchers in vitro could transform the blood transfusion market. A platelet bioreactor was developed by researchers at Brigham and Women's Hospital. The device is modeled after bone marrow and can be used to treat chemotherapy and organ transplant patients, in surgeries and for emergency trauma use. The researchers expect to begin clinical testing in 2017. Story